Background: Recent studies indicate that during regional myocardial is
chemia and subsequent reperfusion, volatile anesthetics may provide pr
otection against free radical-related injury. The effect of halothane
on free radical production during ischemia and reperfusion, in the can
ine heart, was investigated. The level of hydroxyl radical ((OH)-O-.)-
mediated conversion of salicylate to its dehydroxybenzoate derivatives
(2,3-DHBA and 2,5-DHBA) was monitored. Methods: Under general anesthe
sia, the heart was exposed through median sternotomy. Salicylate (100
mg/kg given intravenously) was administered 30 min before left anterio
r descending artery occlusion. Six dogs were studied using inhaled hal
othane (1.6%) 10 min before and during the 10-min ischemic period, fol
lowed by 50 min of reperfusion, and then they were compared with seven
other dogs used as controls. Blood concentrations of salicylate, 2,3-
DHBA and 2,5-DHBA, K+, lactate, oxygen content, and pH were monitored.
Results: An acute increase in the normalized concentrations of 2,3-DH
BA and 2,5-DHBA was observed in the control animals during reperfusion
. In contrast, halothane inhalation completely inhibited the productio
n of both metabolites (P < 0.02), but 2,5-DHBA concentrations in the h
alothane-treated group were even less than the basal level (P < 0.05).
The increase in lactate concentrations in the experimental animals wa
s significantly less than that of controls (P < 0.05) and followed the
same time-dependent pattern as the changes in K+ and pH. Halothane si
gnificantly decreased (P < 0.0001) the difference in oxygen content be
tween coronary sinus and aortic root blood, suggesting decreased oxyge
n utilization during reperfusion. Conclusions: Halothane completely in
hibited the production of (OH)-O-., and its administration may protect
the heart from the deleterious effect of oxygen-derived reactive spec
ies, with attenuation of the metabolic response to ischemia.